(Circulation. 1995;91:1655-1658.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Cardiovascular Medicine, University of New South Wales/Prince Henry Hospital, Sydney, Australia.
Correspondence to Professor David Wilcken, Department of Cardiovascular Medicine, Clinical Sciences Building, Prince Henry Hospital, Little Bay, NSW 2036, Australia.
Background It has been suggested that the insertion/deletion (I/D) polymorphism of the angiotensin-converting enzyme (ACE) gene is an independent risk factor for coronary artery disease. The D/D genotype, which is associated with higher levels of circulating ACE than the I/D or I/I genotype, has been found significantly more frequently in patients with myocardial infarction and also in individuals with a parental history of myocardial infarction.
Methods and Results We explored the distribution of the ACE genotype in 404 school children, aged 6 to 13 years, and related the distribution to the number of their grandparents who had had vascular events. We found a significant association between the number of grandparents who had had coronary events and the ACE genotype (P=.01). In children with two or more grandparents who had had coronary events, there was an excess of both D/D (odds ratio=2.8 [95% confidence interval=1.16-6.56]) and I/D (odds ratio=1.4 [95% confidence interval=0.62-3.25]) genotypes compared with I/I genotypes. In addition, there was an association between the ACE genotype and lipoprotein(a) levels in children (P=.07). Both the ACE genotype and lipoprotein(a) were found to contribute significantly (P=.0042) and independently to family history of coronary artery disease, with the ACE genotype proving to be more predictive than lipoprotein(a) levels.
Conclusions We conclude that the I/D polymorphism of the ACE gene is an important independent risk factor for coronary artery disease and is more predictive that lipoprotein(a). The I/D polymorphism is not only associated with a parental history of myocardial infarction but also with coronary artery disease in second-degree relatives. A further study to explore the relation between the I/D polymorphism and circulating levels of lipoprotein(a) is indicated.
Key Words: angiotensin enzymes coronary disease genes lipoproteins
This article has been cited by other articles:
![]() |
S. Cuomo, P. Guarini, G. Gaeta, M. de Michele, F. Boeri, J. Dorn, M.G. Bond, and M. Trevisan Increased carotid intima-media thickness in children-adolescents, and young adults with a parental history of premature myocardial infarction Eur. Heart J., September 1, 2002; 23(17): 1345 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Mogensen, S. Neldam, I. Tikkanen, S. Oren, R. Viskoper, R. W Watts, and M. E Cooper Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study BMJ, December 9, 2000; 321(7274): 1440 - 1444. [Abstract] [Full Text] |
||||
![]() |
D. Crisan and J. Carr Angiotensin I-Converting Enzyme: Genotype and Disease Associations J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115. [Full Text] |
||||
![]() |
M. Margaglione, G. Cappucci, D. Colaizzo, G. Vecchione, E. Grandone, and G. Di Minno C-Reactive Protein in Offspring Is Associated With the Occurrence of Myocardial Infarction in First-Degree Relatives Arterioscler. Thromb. Vasc. Biol., January 1, 2000; 20(1): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Margaglione, G. Cappucci, D. Colaizzo, N. Giuliani, G. Vecchione, E. Grandone, O. Pennelli, and G. Di Minno The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 152 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2783 - 2792. [Abstract] [Full Text] |
||||
![]() |
Y. Maeda, U. Ikeda, H. Ebata, Y. Hojo, Y. Seino, Y. Hayashi, S. Kuroki, and K. Shimada Angiotensin-Converting Enzyme Gene Polymorphism in Hypertensive Individuals With Parental History of Stroke Stroke, September 1, 1996; 27(9): 1521 - 1523. [Abstract] [Full Text] |
||||
![]() |
N. J. Samani, J. R. Thompson, L. O'Toole, K. Channer, and K. L. Woods A Meta-analysis of the Association of the Deletion Allele of the Angiotensin-Converting Enzyme Gene With Myocardial Infarction Circulation, August 15, 1996; 94(4): 708 - 712. [Abstract] [Full Text] |
||||
![]() |
R. F. Badenhop, X. L. Wang, and D. E.L. Wilcken Association Between an Angiotensinogen Microsatellite Marker in Children and Coronary Events in Their Grandparents Circulation, June 15, 1996; 93(12): 2092 - 2096. [Abstract] [Full Text] |
||||
![]() |
M. Margaglione, E. Celentano, E. Grandone, G. Vecchione, G. Cappucci, N. Giuliani, D. Colaizzo, S. Panico, F. P. Mancini, and G. Di Minno Deletion Polymorphism in the Angiotensin-Converting Enzyme Gene in Patients With a History of Ischemic Stroke Arterioscler. Thromb. Vasc. Biol., February 1, 1996; 16(2): 304 - 309. [Abstract] [Full Text] |
||||
![]() |
X.L. Wang, R.M. McCredie, and D.E.L. Wilcken Genotype Distribution of Angiotensin-Converting Enzyme Polymorphism in Australian Healthy and Coronary Populations and Relevance to Myocardial Infarction and Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 115 - 119. [Abstract] [Full Text] |
||||
![]() |
E. Haber Angiotensin-Converting Enzyme and Lipoprotein(a) as Risk Factors for Myocardial Infarction Circulation, March 15, 1995; 91(6): 1888 - 1890. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |